By Natalie Grover LONDON (Reuters) – Surging energy costs in Europe risk accelerating the exodus of companies critical to the manufacture of essential medicines, further endangering drug supply chains hit by shortages at the height of COVID-19, pharmaceutical firm Teva said in a report on
